176 related articles for article (PubMed ID: 35642672)
1. Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.
Huang X; Huang Y; Lv Z; Wang T; Feng H; Wang H; Du S; Wu S; Shen D; Wang C; Li H; Wang B; Ma X; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642672
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Chong Y; Xue L
Crit Rev Eukaryot Gene Expr; 2021; 31(1):29-40. PubMed ID: 33639053
[TBL] [Abstract][Full Text] [Related]
3. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
4. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
5. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
6. CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling.
Wang X; Shi A; Liu J; Kong W; Huang Y; Xue W; Yang F; Huang J
Cancer Cell Int; 2024 Apr; 24(1):147. PubMed ID: 38658931
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
8. KLF5-mediated CDCA5 expression promotes tumor development and progression of epithelial ovarian carcinoma.
Chen X; Zhou M; Ma S; Wu H; Cai H
Exp Cell Res; 2023 Aug; 429(1):113645. PubMed ID: 37247719
[TBL] [Abstract][Full Text] [Related]
9. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
10. CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker.
Hu H; Xiang Y; Zhang XY; Deng Y; Wan FJ; Huang Y; Liao XH; Zhang TC
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004470
[TBL] [Abstract][Full Text] [Related]
11. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A.
Wang Y; Yao J; Zhu Y; Zhao X; Lv J; Sun F
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35506437
[TBL] [Abstract][Full Text] [Related]
13. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
Zhang Q; Zhang R; Li Y; Yang X
J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
[TBL] [Abstract][Full Text] [Related]
14. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
16. Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma.
Hou S; Chen X; Li M; Huang X; Liao H; Tian B
Aging (Albany NY); 2020 Jul; 12(14):14542-14555. PubMed ID: 32694239
[TBL] [Abstract][Full Text] [Related]
17. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
[TBL] [Abstract][Full Text] [Related]
18. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
Tian Y; Wu J; Chagas C; Du Y; Lyu H; He Y; Qi S; Peng Y; Hu J
BMC Cancer; 2018 Nov; 18(1):1187. PubMed ID: 30497429
[TBL] [Abstract][Full Text] [Related]
19. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
